Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

A young girl with skin and scalp conditions showed some improvement with treatment.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Skin problems after waxing led to a sarcoidosis diagnosis.

Vitiligo and lupus can occur together, requiring careful treatment to manage both conditions.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

EPDS and MS might share an immune-related cause.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Blocking JAK-STAT signaling can lead to hair growth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Immune cells affect hair growth and could lead to new hair loss treatments.